Beyond Hot Flashes: How Our Understanding of Menopause and VMS Has Evolved

Welcome back to another Pharmacy Times Peer Exchange series. In this episode titled, 'Beyond Hot Flashes: How Our Understanding of Menopause and VMS Has Evolved,' Brooke Griffin, PharmD, BCACP, led the conversation about the following questions:

1. How has our scientific understanding of menopause and vasomotor symptoms (VMS) changed over the past 20 years?
2. How has the scientific community's view on hormonal therapy efficacy and safety evolved over the last 20 years?
3. What do the major guidelines currently say about the treatment of VMS, and where does hormonal therapy stand?

The panelists highlighted how the scientific understanding of VMS has fundamentally shifted over the past two decades, moving away from a simplistic view of VMS as a minor estrogen withdrawal nuisance toward recognition of its neurological origins in the hypothalamus, its broad systemic impact on sleep, cognition, and daily functioning, and its potential role as a risk factor for adverse cardiovascular outcomes. The discussion also explored the evolving epidemiology of VMS, noting that symptoms can persist for 7 to 10 years on average with meaningful variation across demographic groups, underscoring that this is a serious and prolonged health concern deserving rigorous clinical attention. The panelists also traced the dramatic pendulum swing in the medical community's view of hormone therapy, from the widespread fear and rapid deprescription triggered by the Women's Health Initiative to the current evidence-based consensus supporting a favorable benefit-to-risk ratio for most women who initiate therapy within 10 years of their final menstrual period, while noting that significant work remains to educate primary care providers, gynecologists, and pharmacists on these updated guidelines.

Throughout the conversation, the experts provide a comprehensive reflection on the field and the factors that may shape how clinicians approach care moving forward.

In the next episode, 'Closing the Knowledge Gap: What Community Pharmacists Need to Know About Menopause,' panelists will continue their discussion on vasomotor symptoms and menopause and highlight the most critical knowledge gaps among community pharmacists, the real-world clinical errors these gaps can produce, and why ensuring pharmacists are current on the latest menopause literature and guidelines is essential to improving patient outcomes.